Atatürk Üniversitesi Atatürk Üniversitesi
Ara
Yayınlara dön
Makale Tam Makale Uluslararası 2015

Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival

Ömer Araz, Elif Yılmazel Uçar, Mehmet MERAL, Aslihan Yalcin, Hamit ACEMOĞLU, Hasan DOĞAN, Adem Karaman, Yener Aydın, Metin Gorguner, Metin AKGÜN

CLINICAL RESPIRATORY JOURNAL Cilt 9 · Sayı 3 · ss. 297–304 · 01.07.2015
DOI ile aç

Özet

IntroductionLung cancer is the most common cause of cancer death in the world, and the most common type is non-small-cell lung cancer (NSCLC). At present, surgical resection, chemotherapy, and radiation therapy are the main treatments for patients with NSCLC, but unfortunately outcome remains unsatisfactory.

Anahtar kelimeler

SURVIVAL EXPRESSION PROLIFERATION VIVO LUNG-CANCER SOLID TUMORS drug resistance Interferon CARCINOMA Class I and II HLA alleles response to chemotherapy INFLAMMATORY FACTOR-I PROGNOSTIC-FACTOR ANTIGEN

Sürdürülebilir Kalkınma Amaçları

  • SKA 3: Sağlıklı Bireyler

Atıf için künye

Araz, Ö., Yılmazel Uçar, E., MERAL, M., Yalcin, A., ACEMOĞLU, H., DOĞAN, H., Karaman, A., Aydın, Y., Gorguner, M., & AKGÜN, M. (2015). Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival. CLINICAL RESPIRATORY JOURNAL, 9(3), 297–304. https://doi.org/10.1111/crj.12143

BibTeX
@article{araz2015-214141,
  author = {Araz, Ömer and Yılmazel Uçar, Elif and MERAL, Mehmet and Yalcin, Aslihan and ACEMOĞLU, Hamit and DOĞAN, Hasan and Karaman, Adem and Aydın, Yener and Gorguner, Metin and AKGÜN, Metin},
  title = {Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival},
  journal = {CLINICAL RESPIRATORY JOURNAL},
  year = {2015},
  volume = {9},
  number = {3},
  pages = {297--304},
  issn = {1752-6981},
  doi = {10.1111/crj.12143},
  url = {https://akademik.atauni.edu.tr/yayinlar/214141-frequency-of-class-i-and-ii-hla-alleles-in-patients-with-lung-cancer-according}
}